308.84
Overview
News
Price History
Option Chain
Financials
Why SYK Down?
Discussions
Forecast
Stock Split
Dividend History
Stryker Corp stock is traded at $308.84, with a volume of 1.68M.
It is down -1.65% in the last 24 hours and up +8.19% over the past month.
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.
See More
Previous Close:
$314.01
Open:
$314.72
24h Volume:
1.68M
Relative Volume:
0.67
Market Cap:
$118.40B
Revenue:
$25.27B
Net Income/Loss:
$3.34B
P/E Ratio:
35.77
EPS:
8.6334
Net Cash Flow:
$4.57B
1W Performance:
+4.69%
1M Performance:
+8.19%
6M Performance:
-12.71%
1Y Performance:
-19.79%
Stryker Corp Stock (SYK) Company Profile
Name
Stryker Corp
Sector
Industry
Phone
(269) 385-2600
Address
1941 STRYKER WAY, PORTAGE, MI
Compare SYK vs ABT, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
SYK
Stryker Corp
|
308.84 | 120.38B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
ABT
Abbott Laboratories
|
89.17 | 158.94B | 45.13B | 6.28B | 7.38B | 3.5895 |
|
MDT
Medtronic Plc
|
80.25 | 105.25B | 36.36B | 4.84B | 5.43B | 3.7212 |
|
BSX
Boston Scientific Corp
|
48.34 | 72.77B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
85.98 | 50.41B | 6.30B | 1.07B | 1.09B | 1.8406 |
Stryker Corp Stock (SYK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-13-26 | Initiated | Leerink Partners | Outperform |
| Feb-20-26 | Initiated | William Blair | Outperform |
| Jan-27-26 | Resumed | TD Cowen | Hold |
| Jan-06-26 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-19-25 | Upgrade | Citizens JMP | Mkt Perform → Mkt Outperform |
| Sep-18-25 | Initiated | Rothschild & Co Redburn | Neutral |
| Feb-26-25 | Resumed | Citigroup | Buy |
| Dec-02-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-10-24 | Initiated | Wolfe Research | Outperform |
| May-30-24 | Initiated | Goldman | Neutral |
| May-22-24 | Upgrade | Needham | Hold → Buy |
| Jan-31-24 | Upgrade | Canaccord Genuity | Hold → Buy |
| Oct-20-23 | Initiated | ROTH MKM | Buy |
| Sep-05-23 | Upgrade | BofA Securities | Neutral → Buy |
| Mar-29-23 | Initiated | UBS | Neutral |
| Jan-25-23 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jan-09-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-01-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-28-22 | Upgrade | Edward Jones | Hold → Buy |
| Jul-21-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jul-11-22 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-13-22 | Initiated | Truist | Hold |
| Mar-16-22 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Mar-15-22 | Resumed | Evercore ISI | Outperform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-10-21 | Initiated | RBC Capital Mkts | Sector Perform |
| Dec-07-21 | Initiated | Loop Capital | Buy |
| Sep-14-21 | Resumed | Raymond James | Mkt Perform |
| Jul-28-21 | Upgrade | Northland Capital | Market Perform → Outperform |
| Jun-01-21 | Upgrade | Evercore ISI | In-line → Outperform |
| May-25-21 | Initiated | Barclays | Underweight |
| Oct-06-20 | Initiated | Northland Capital | Market Perform |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| Apr-13-20 | Downgrade | Barclays | Equal Weight → Underweight |
| Apr-01-20 | Downgrade | Goldman | Buy → Sell |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Buy |
| Jan-08-20 | Initiated | SunTrust | Hold |
| Jan-07-20 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jan-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-30-19 | Reiterated | BTIG Research | Buy |
| Nov-05-19 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-30-19 | Reiterated | BofA/Merrill | Buy |
| Jul-02-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-30-19 | Reiterated | Canaccord Genuity | Buy |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Jan-02-19 | Upgrade | Evercore ISI | In-line → Outperform |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Aug-16-18 | Initiated | BTIG Research | Buy |
| Jun-27-18 | Initiated | Bernstein | Mkt Perform |
| Apr-27-18 | Reiterated | Stifel | Buy |
View All
Stryker Corp Stock (SYK) Latest News
Stryker Corp Stock (US8636671013): In focus on a quiet news day - AD HOC NEWS
ThruFlo Endovascular Secures Seed Funding to Advance First Purpose-Built Flow Diverter for Bifurcation Aneurysms - GlobeNewswire Inc.
Stryker Corp. stock (US8636671013): shares retreat after recent jump despite solid medical technolog - AD HOC NEWS
Stryker’s Pangea Europe Launch And What It Means For NYSE SYK Investors - Yahoo Finance UK
A Look at Stryker Corp (SYK) After 4.1% Gain -- GF Value $408.95 vs Price $314.01 - GuruFocus
Stryker Corp. stock (US8636671013): Q1 miss keeps medtech heavyweight in focus - AD HOC NEWS
Is Stryker stock underperforming the S&P 500? - MSN
Marks Group Wealth Management Inc Sells 7,418 Shares of Stryker Corporation $SYK - MarketBeat
Stryker Corporation $SYK Position Lifted by Fiera Capital Corp - MarketBeat
Stryker Corp stock (US8636671013): medtech heavyweight after strong Q1 update - AD HOC NEWS
Stryker Corp. stock underperforms Monday when compared to competitors - MarketWatch
Stryker CEO says cyberattack won’t slow AI expansion - Crain's Grand Rapids Business
Stryker Corp. stock (US8636671013): medical technology leader after latest quarterly update - AD HOC NEWS
Stryker Corporation (SYK) Expands Trauma Portfolio with Pangea Plating System Platform in Europe - Insider Monkey
Stryker’s Kevin Lobo on provider needs, AI and cyberattacks - Modern Healthcare
Vise Technologies Inc. Purchases 3,531 Shares of Stryker Corporation $SYK - MarketBeat
Stryker Corporation $SYK Shares Acquired by ING Groep NV - MarketBeat
Havemeyer Place LP Takes Position in Stryker Corporation $SYK - MarketBeat
Stryker Corporation $SYK Shares Sold by BI Asset Management Fondsmaeglerselskab A S - MarketBeat
SYK Maintained by Leerink Partners -- Price Target Lowered to $4 - GuruFocus
Stryker Corp. stock outperforms competitors on strong trading day - MarketWatch
Stryker Corp stock (US8636671013): valuation metrics in focus after strong first-quarter results - AD HOC NEWS
These are the Michigan companies on this year's Fortune 500 list - The Detroit News
Leerink cuts Stryker stock price target to $407 on model update - Investing.com UK
Leerink cuts Stryker stock price target to $407 on model update By Investing.com - Investing.com South Africa
Stryker Corp. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Stryker Launches TPX HD Power Tool for Complex Orthopedic Procedures - The Globe and Mail
Natixis Advisors LLC Sells 57,151 Shares of Stryker Corporation $SYK - MarketBeat
Stryker Unveils TPX HD As Stock Trades Below Analyst Targets - Yahoo Finance
Stryker Corp. stock (US8636671013): new TPX HD tool launch as shares trade near 52-week lows - AD HOC NEWS
Kesler Norman & Wride LLC Has $6.22 Million Stock Holdings in Stryker Corporation $SYK - MarketBeat
Bank of New York Mellon Corp Sells 225,535 Shares of Stryker Corporation $SYK - MarketBeat
Stryker (SYK): Company Profile, Stock Price, News, Rankings - Fortune
Stryker Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
Stryker (SYK) COO Spencer Stiles donates 1,607 shares in Form 4 gift - Stock Titan
Stryker launches TPX HD power tool for orthopaedic procedures - Investing.com
Stryker launches TPX HD® power tool, supporting demanding orthopaedic procedures – Company Announcement - Financial Times
Stryker Corporation $SYK Stake Increased by AXQ Capital LP - MarketBeat
Inside Stryker’s new high-torque drill built for tough bone surgeries - Stock Titan
Is Stryker Stock Underperforming the S&P 500? - Barchart
Nomura Asset Management Co. Ltd. Sells 4,528 Shares of Stryker Corporation $SYK - MarketBeat
MUFG Securities EMEA plc Acquires 7,524 Shares of Stryker Corporation $SYK - MarketBeat
Stryker launches Pangea plating system in Europe for fracture fixation - MSN
Stryker Corp. stock (US8636671013): Insider sale by legal chief draws focus to institutional ownersh - AD HOC NEWS
Ilmarinen Mutual Pension Insurance Co Takes Position in Stryker Corporation $SYK - MarketBeat
Fideuram Asset Management Ireland dac Invests $1.44 Million in Stryker Corporation $SYK - MarketBeat
Stryker VP, chief legal officer Robert Fletcher sells $1.39m in shares - Investing.com Nigeria
Stryker VP, chief legal officer Robert Fletcher sells $1.39m in shares By Investing.com - Investing.com South Africa
Stryker Insider Sold Shares Worth $1,394,409, According to a Recent SEC Filing - Moomoo
Stryker (SYK) legal chief sells 4,544 shares under Rule 10b5-1 plan - Stock Titan
Hedge Fund and Insider Trading News: Ken Griffin, Michael Burry, Bill Ackman, Warren Buffett, Voss Capital, Cinctive Capital Management, Stryker Corp (SYK), Twilio Inc (TWLO), and More - Insider Monkey
Stryker Corp Stock (SYK) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):